opioids
Historical Context
Opioids have a complex history: initially praised for their medicinal benefits, later criticized for their addictive properties.
Commonly prescribed for analgesia (pain relief).
Early Use
Opium usage dates back to the late 1800s, with products like laudanum and paragoric available over the counter.
Bayer company used to include heroin in their medications.
Current Perceptions
Shifted from common medicinal use to scrutiny concerning addiction and overdose.
Categories
Natural, semi-synthetic, and synthetic opioids.
Examples of natural derivatives: morphine and codeine.
Synthetic examples include fentanyl and methadone.
Opioid Receptors
Four primary receptor types: mu, delta, kappa, and nociceptin.
Mu receptors are primarily targeted by most clinically relevant opioids.
Effects of Opioids
Produce analgesia and can induce euphoria.
Side effects: cough suppression, reduction of diarrhea, potential for addiction.
High tolerance potential; dependency and uncomfortable withdrawal symptoms.
Overdose Statistics
Overdose rates have increased significantly, particularly with synthetic opioids like fentanyl.
Comparisons show opioids to have higher mortality rates compared to other drugs.
Health Risks
Risks include cognitive impairment and respiratory depression, especially when combined with other sedatives like alcohol.
Opioid overdose can lead to the opioid triad: coma, depressed respiration, and pinpoint pupils.
Pain Types
Acute pain: Immediate response, adaptive function post-injury.
Chronic pain: Ongoing, maladaptive, causes misery.
Nociception
The process of sensing pain; nociceptors are the receptors involved in this process.
The body's response differentiates between early (acute) and late (chronic) pain pathways.
Pain Pathways
Ascending pathways send pain signals to the brain.
Early pain activates the primary somatosensory cortex; late pain is processed in the anterior cingulate cortex.
Descending Modulation
Periaqueductal gray (PAG) is crucial in modulating pain signals, rich in opioid receptors.
Opioids influence both ascending and descending pathways, blocking pain signaling.
Risk Factors
Family history, young age, prior substance abuse, high-risk environments.
Addiction onset occurs, on average, after a year of use.
Statistics
Less than 5% of chronic pain patients prescribed opioids become addicted.
Around 25% of heroin users develop a full addiction.
Reward Circuitry
Involves the ventral tegmental area, which has connections to the nucleus accumbens and prefrontal cortex.
Mechanism of Addiction
Opioids block GABAergic inhibition of dopamine neurons, leading to increased dopamine release and enhanced reward feelings.
Overview
An unregulated herbal substance that stimulates mu opioid receptors and affects serotonin and norepinephrine.
Used for anxiety, pain relief, and as a self-medication for opioid dependence.
Potential Risks
Impairment of cognition and high rates of addiction.
Respiratory depression, particularly risky in combination with CNS depressants.
Characteristics
Pain sensitivity, insomnia, and anxiety during withdrawal compared to drug effects.
Withdrawals typically start within days of cessation and can last around five days.
Options
Ultra Rapid Detox: Anesthetized patients receive clonidine and naltrexone to reduce withdrawal symptoms.
Methadone: A full agonist that requires daily administration for extended periods.
Buprenorphine: A partial agonist that can help wean individuals off opioids, with lower addictive risks.
Heroin Maintenance: Medically supervised heroin administration is available in certain regions, providing harm reduction.
Historical Context
Opioids have a complex history: initially praised for their medicinal benefits, later criticized for their addictive properties.
Commonly prescribed for analgesia (pain relief).
Early Use
Opium usage dates back to the late 1800s, with products like laudanum and paragoric available over the counter.
Bayer company used to include heroin in their medications.
Current Perceptions
Shifted from common medicinal use to scrutiny concerning addiction and overdose.
Categories
Natural, semi-synthetic, and synthetic opioids.
Examples of natural derivatives: morphine and codeine.
Synthetic examples include fentanyl and methadone.
Opioid Receptors
Four primary receptor types: mu, delta, kappa, and nociceptin.
Mu receptors are primarily targeted by most clinically relevant opioids.
Effects of Opioids
Produce analgesia and can induce euphoria.
Side effects: cough suppression, reduction of diarrhea, potential for addiction.
High tolerance potential; dependency and uncomfortable withdrawal symptoms.
Overdose Statistics
Overdose rates have increased significantly, particularly with synthetic opioids like fentanyl.
Comparisons show opioids to have higher mortality rates compared to other drugs.
Health Risks
Risks include cognitive impairment and respiratory depression, especially when combined with other sedatives like alcohol.
Opioid overdose can lead to the opioid triad: coma, depressed respiration, and pinpoint pupils.
Pain Types
Acute pain: Immediate response, adaptive function post-injury.
Chronic pain: Ongoing, maladaptive, causes misery.
Nociception
The process of sensing pain; nociceptors are the receptors involved in this process.
The body's response differentiates between early (acute) and late (chronic) pain pathways.
Pain Pathways
Ascending pathways send pain signals to the brain.
Early pain activates the primary somatosensory cortex; late pain is processed in the anterior cingulate cortex.
Descending Modulation
Periaqueductal gray (PAG) is crucial in modulating pain signals, rich in opioid receptors.
Opioids influence both ascending and descending pathways, blocking pain signaling.
Risk Factors
Family history, young age, prior substance abuse, high-risk environments.
Addiction onset occurs, on average, after a year of use.
Statistics
Less than 5% of chronic pain patients prescribed opioids become addicted.
Around 25% of heroin users develop a full addiction.
Reward Circuitry
Involves the ventral tegmental area, which has connections to the nucleus accumbens and prefrontal cortex.
Mechanism of Addiction
Opioids block GABAergic inhibition of dopamine neurons, leading to increased dopamine release and enhanced reward feelings.
Overview
An unregulated herbal substance that stimulates mu opioid receptors and affects serotonin and norepinephrine.
Used for anxiety, pain relief, and as a self-medication for opioid dependence.
Potential Risks
Impairment of cognition and high rates of addiction.
Respiratory depression, particularly risky in combination with CNS depressants.
Characteristics
Pain sensitivity, insomnia, and anxiety during withdrawal compared to drug effects.
Withdrawals typically start within days of cessation and can last around five days.
Options
Ultra Rapid Detox: Anesthetized patients receive clonidine and naltrexone to reduce withdrawal symptoms.
Methadone: A full agonist that requires daily administration for extended periods.
Buprenorphine: A partial agonist that can help wean individuals off opioids, with lower addictive risks.
Heroin Maintenance: Medically supervised heroin administration is available in certain regions, providing harm reduction.